Keyphrases
Anticancer
100%
Porphyrin Complex
100%
Complex Effects
100%
Gold(III)
100%
Porphyrin Structure
100%
Porphyrin
50%
Cancer Cells
25%
Tetrakis
16%
IC50
16%
Meso
16%
Structure-activity Relationship
8%
G-quadruplex
8%
G-quadruplex Structure
8%
Polymerase Chain Reaction
8%
Cell Death
8%
Lipophilicity
8%
Inhibitory Effect
8%
Structural Modification
8%
Binding Constant
8%
Cellular Uptake
8%
Induced Apoptosis
8%
IC50 Value
8%
Absorption Titration
8%
Conjugation
8%
Anti-apoptotic Bcl-2
8%
Anticancer Activity
8%
Flow Cytometric Analysis
8%
Less Toxic
8%
Peripheral Substituents
8%
Sigma Phase
8%
Chelates
8%
TMPyP4
8%
Antiangiogenic Properties
8%
Antiangiogenic Activity
8%
Apoptosis-inducing Activity
8%
Saccharides
8%
Telomerase
8%
Aryl Rings
8%
Topoisomerase
8%
Viscosity Measurement
8%
Supercoiled DNA
8%
DNA Substrates
8%
Non-cancer
8%
Lung Fibroblasts
8%
Gel Shift Assay
8%
1-methyl-4-phenylpyridinium
8%
Cytostatic Activity
8%
Docking Experiments
8%
Computational Docking
8%
Protein Expression Analysis
8%
DNA Intercalation
8%
Cellcycle
8%
Ligand System
8%
Preferential Cytotoxicity
8%
Termination of DNA Replication
8%
Ethidium Bromide
8%
Tetraarylporphyrins
8%
Chemistry
Porphyrin
100%
DNA
54%
IC50
27%
Antiangiogenic
18%
Kd
9%
Carbohydrate
9%
Bioactivity
9%
Toxic
9%
Lipophilicity
9%
Relaxation
9%
Cell Death
9%
Electrophoretic Mobility-Shift Assay
9%
N-Methylpyridinium
9%
Ethidium Bromide
9%
Antiapoptotic
9%
Pharmacology, Toxicology and Pharmaceutical Science
Porphyrin
100%
Malignant Neoplasm
27%
IC50
27%
Guanine Quadruplex
18%
Antiangiogenic
18%
Carbohydrate
9%
Cytotoxicity
9%
Lipophilicity
9%
Antiapoptotic
9%
Protein Bcl 2
9%
Telomerase
9%
DNA Topoisomerase
9%
Ethidium Bromide
9%
Cytostatic
9%
Intercalating Agent
9%
Electrophoretic Mobility Shift Assay
9%